Subscribe To
Albemarle 3q results miss; lithium miner cuts 2023 outlook
Albemarle Corporation (NYSE:ALB) after Wednesday's close announced third quarter 2023 adjusted earnings per share (EPS) of $2.74, falling short of the...
November 2, 2023, 10:16 am
Investors funnel capital into xage as demand for zero trust cybersecurity mesh skyrockets
$20M in Additional Funding To Accelerate Go-To-Market and Product Investments PALO ALTO, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) — Xage Security, the...
November 2, 2023, 10:10 am
David harris jr. appointed as global warming solutions’ spokesperson to power the planet’s transition to clean energy
Temecula, CA , Nov. 02, 2023 (GLOBE NEWSWIRE) — Global Warming Solutions, Inc. (GWSO), a worldwide developer of green technologies to mitigate clima...
November 2, 2023, 10:00 am
Affirm's stock explodes higher after expanded amazon arrangement
Affirm Holdings Inc. shares AFRM, +16.08% were powering 16% higher in Thursday morning action after Amazon.com Inc. AMZN, +0.49% announced that it wou...
November 2, 2023, 9:56 am
Rollins to present at upcoming investor conferences
ATLANTA , Nov. 2, 2023 /PRNewswire/ -- Rollins, Inc. (NYSE: ROL) ("Rollins" or the "Company"), a premier global consumer and commercial services compa...
November 2, 2023, 9:49 am
Wall street to turn around in final months of 2023: 5 winners
Since the stock market is poised to bounce back in the final months of this year, it's prudent to inves...
November 2, 2023, 9:46 am
Adamas one announces first delivery of lab-grown colorless diamonds
Adamas One Corp has reported the initial delivery of colorless diamonds in the D, E, and F color range. The lab-grown diamond manufacturer said th...
November 2, 2023, 9:40 am
Novavax to host conference call to discuss third quarter 2023 financial results and operational highlights on november 9, 2023
GAITHERSBURG, Md. , Nov. 2, 2023 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™...
November 2, 2023, 9:25 am
Lucid diagnostics to present at canaccord genuity medtech, diagnostics, and digital health & services forum
Lishan Aklog, M.D., Chairman & CEO, to Present November 16, 2023, in New York NEW YORK , Nov. 2, 2023 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq...
November 2, 2023, 9:18 am
In8bio to present new positive data from phase 1 trial of inb-100 at 2023 american society of hematology (ash) annual meeting
NEW YORK, Nov. 02, 2023 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta ...
November 2, 2023, 9:17 am
Corvus pharmaceuticals to present new interim soquelitinib data from its phase 1/1b t cell lymphoma trial at the 65th american society of hematology (ash) annual meeting & exposition
BURLINGAME, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today ...
November 2, 2023, 9:15 am
After a year colt seals the $1.8b purchase of lumen emea
Colt, a service provider for numerous retail brokers, financial firms, and crypto exchanges, announced today (Thursday) that it has acquired Lumen EME...
November 2, 2023, 9:14 am
Sidus space awarded multi-million-dollar contract for commercial lunar transportation
Sidus Space Inc (NASDAQ:SIDU) announced that it has been awarded a five-year Indefinite-Delivery/Indefinite-Quantity (IDIQ) contract, with a $10 mil...
November 2, 2023, 9:13 am
Vincerx pharma to present three posters at ash 2023 in december
VIP943 poster supports selectivity and safety of lead CD123 ADC, VIP943, currently in Phase 1 VIP924 poster shows this novel CXCR5-ADC compares favora...
November 2, 2023, 9:10 am
Centessa pharmaceuticals to present additional 52-weeks of continuous treatment data from third year of ongoing phase 2a study of serpinpc for the treatment of hemophilia at american society of hemato
BOSTON and LONDON, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA) today announced that new data from an additional 52-w...
November 2, 2023, 9:09 am
Centessa pharmaceuticals to present additional 52-weeks of continuous treatment data from third year of ongoing phase 2a study of serpinpc for the treatment of hemophilia at american society of hemato
BOSTON and LONDON, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA) today announced that new data from an additional 52-w...
November 2, 2023, 9:09 am
Pineapple express cannabis company to launch 9 additional dispensaries in metro los angeles to accompany pineapple express hollywood flagship
Company’s 50% owned asset signs agreements to manage 9 additional dispensaries in metro Los Angeles; Company holds equity in all LOS ANGELES, CA, No...
November 2, 2023, 9:00 am
Eur/nok to return towards 11.90 if norges bank’s statement sounds more cautious – commerzbank
GBP/USD has entered a phase of consolidation after running into the 1.2200 barrier. Pound Sterling bulls catch a breather, gearing up for the Bank of ...
November 2, 2023, 8:59 am
Cematrix to report third quarter results on november 8, 2023 earnings webinar scheduled for 1:00 p.m. et, november 9, 2023
CALGARY, Alberta, Nov. 02, 2023 (GLOBE NEWSWIRE) -- CEMATRIX Corporation (TSXV: CVX) (OTCQB: CTXXF) ("CEMATRIX" or the "Company") a North American lea...
November 2, 2023, 8:30 am
Pi cryptocurrency: price forecasts and future potential
Understanding Pi Cryptocurrency: Price Forecasts and Future Potential Investors in the cryptocurrency sphere are perpetually in search of the next maj...
November 2, 2023, 8:15 am